The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines
Clinical trial NCT05364580 · COMPLETED
Trial details
- NCT number
- NCT05364580
- Sponsor
- Protox Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2023-06-20
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.